MDMA/Psilocybin treatment for Long-COVID wins first place

Congratulations on First Place in poster presentations at the Eastern Pain Association conference, "Long-Covid Symptoms Improved after MDMA and Psilocybin Therapy", to combined teams from the Center for Psychedelic Research at UCSD, UT San Antonio Rehabilitation Medicine, Johns Hopkins Physical Medicine & Rehabilitation, & NYU Grossman School of Medicine; amazing effort to all involved.

Gratifying to see these names here: Dr. Joel Castellanos, Dr. Timothy Furnish, Dr Monica Verduzco-Gutierrez, Dr. Harman Chopra, & Dr. David Jevotovsky, all advancing crucial research for relief from #LongCovid. REMAP also had some involvement in the inception and organizations of this case study that we plan on sharing soon.

Looking forward to expanded research that is soon to be published on this likely first reported case-study of psychedelics as treatment for Long-COVID. The Psychedelics & Pain Association's (PPA) open coursework, “Introduction to Psychedelics for Chronic Pain”, will contain an interview with subject of case study herself.

First Place poster-presentation at Eastern Pain Association conference